Insider Stock Trading History of Maimon Yossi


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Maimon Yossi since year 2005. The trader's CIK number is 1385115. At the time of this reporting, Maimon Yossi is the Vice President & CFO of Protalix Biotherapeutics, Inc. . (stock ticker symbol PLX). See this page for all insider trading activities at Protalix Biotherapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Maimon Yossi since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-12-14 PLX Protalix Biotherapeutics, Inc. Buy 10,000 .78 7,800
2012-05-02 PLX Protalix Biotherapeutics, Inc. Option Ex 125,964 1.81 228,120
2012-05-02 PLX Protalix Biotherapeutics, Inc. Sale 125,964 7.13 898,123
2010-10-07 PLX Protalix Biotherapeutics, Inc. Option Ex 77,769 .97 75,591
2010-10-07 PLX Protalix Biotherapeutics, Inc. Sale 70,000 9.67 676,900
2010-09-07 PLX Protalix Biotherapeutics, Inc. Sale 31,500 8.16 257,040
2010-09-07 PLX Protalix Biotherapeutics, Inc. Option Ex 70,000 .97 68,040
2010-09-03 PLX Protalix Biotherapeutics, Inc. Sale 38,500 8.00 308,000
2009-10-16 PLX Protalix Biotherapeutics, Inc. Sale 40,300 9.35 376,805
2009-10-16 PLX Protalix Biotherapeutics, Inc. Option Ex 167,698 .97 163,002
2009-10-15 PLX Protalix Biotherapeutics, Inc. Sale 109,700 9.50 1,042,150
2009-07-07 PLX Protalix Biotherapeutics, Inc. Option Ex 62,217 .97 60,474
2009-07-06 PLX Protalix Biotherapeutics, Inc. Sale 40,000 5.13 205,200
2009-07-07 PLX Protalix Biotherapeutics, Inc. Sale 10,000 5.01 50,100
2009-05-18 PLX Protalix Biotherapeutics, Inc. Sale 30,000 4.00 120,000
2009-05-18 PLX Protalix Biotherapeutics, Inc. Option Ex 40,348 .97 39,218
2009-03-13 PLX Protalix Biotherapeutics, Inc. Option Ex 39,800 .97 38,685
2009-03-11 PLX Protalix Biotherapeutics, Inc. Sale 8,849 2.30 20,352
2009-03-13 PLX Protalix Biotherapeutics, Inc. Sale 7,500 2.23 16,725
2009-03-12 PLX Protalix Biotherapeutics, Inc. Sale 32,241 2.22 71,575
2008-02-25 PLX Protalix Biotherapeutics, Inc. Sale 33,300 3.18 105,760
2008-02-22 PLX Protalix Biotherapeutics, Inc. Option Ex 86,176 .97 83,763

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Maimon Yossi (Vice President & CFO of Protalix Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.